Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres

Journal of Biomedical Materials Research

Volumn 42, Issue 2, 1998, Pages 331-338

  Suh, Hearan ^a   Jeong, Byeongmoon ^a   Rathi, Ramesh ^b   Kim, Sung Wan ^a  

^a UNIVERSITY OF UTAH   (United States)

^b MacroMed Inc   (United States)

Author keywords

Endocytosis; Nanosphere; Paclitaxel; Restenosis; Smooth muscle cell

Indexed keywords

ANIMAL CELL CULTURE; BIODEGRADATION; CONTROLLED DRUG DELIVERY; CYTOLOGY; EVAPORATION; MICROSCOPIC EXAMINATION; MUSCLE; POLYETHYLENE OXIDES;

CONFOCAL FLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; PINOCYTOSIS; POLYLACTIDE GLYCOLIDE;

BIOMATERIALS;

MACROGOL; NANOPARTICLE; NONOXINOL 9; PACLITAXEL; POLYGLACTIN;

ANIMAL CELL; ARTICLE; BIODEGRADATION; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENDOCYTOSIS; NONHUMAN; PINOCYTOSIS; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR LESION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL DIVISION; CELLS, CULTURED; LACTIC ACID; MICROSCOPY, CONFOCAL; MICROSPHERES; MUSCLE, SMOOTH, VASCULAR; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS;

EID: 0032210766     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L     Document Type: Article

References (28)

1. M. C. Davies and P. O. Hagen, "Pathobiology of intimai hyperplasia," Br. J. Surg., 81, 1254-1269 (1994).
2. A. W. Clowes, "Intimal hyperplasia and graft failure," Cardiovasc. Pathol., 2 (3), 179-186 (1993).
3. S. E. Epstein, E. Speir, E. F. Unger, R. J. Guzman, and T. Finkel, "The basis of molecular strategies for treating coronary restenosis after angioplasty," J. Am. Coll. Cardiol., 23 (6), 1278-1288 (1994).
4. A. W. Clowes and M. A. Reidy, "Prevention of stenosis after vascular reconstruction: Pharmacological control of intimai hyperplasia - A review," J. Vasc. Surg., 13, 885-891 (1991).
5. M. Nobuyoshi, T. Kimura, and H. Noksaka, "Restenosis after successful coronary angioplasty: Serial angiographic follow-up of 229 patients," J. Am. Coll. Cardiol., 12, 616-623 (1988).
6. R. Ross and J. Glomset, "Atherosclerosis and the arterial smooth muscle cell," Science, 180, 1332-1339 (1973).
7. A. W. Clowes, M. A. Reidy, and M. M. Clowes, "Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium," Lab. Invest., 49, 327-333 (1983).
8. E. R. Edelman and M. J. Karnovsky, "Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis," Circulation, 89, 770-776 (1994).
9. E. R. Edelman, "Perivascular delivery of heparin regulates myointimal hyperplasia," Reactive Polym., 25, 149-156 (1995).
10. D. Mishaly, I. Fishbein, D. Moscovitz, and G. Golomb, "Sitespecific delivery of colchicine in rat carotid artery model of restenosis," J. Controlled Release, 45, 65-73 (1997).
11. E. R. Edelman, M. Simons, M. Sirois, and R. D. Rosenberg, "c-myc in vasculoproliferative disease," Circ. Res., 76, 176-182 (1995).
12. E. R. Edelman, D. H. Adams, and M. J. Karnovsky, "Effect of controlled adventitial heparin delivery on smooth muscle proliferation following endothelial injury," Proc. Natl Acad. Sci. U.S.A., 87, 3773-3777 (1989).
13. A. E. Villa, L. A. Guzman, W. Chen, G. Golomb, R. Levy, and E. Topol, "Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty," J. Clin. Invest., 93, 1243-1249 (1994).
14. R. L. Wilensky, K. L. March, and D. R. Hathaway, "Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty," Am. Heart J., 122, 1136-1140 (1991).
15. H. Wolinsky and S. N. Thung, "Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery," J. Am. Coll. Cardiol., 15, 475-481 (1990).
16. C. R. Lambert, J. E. Leone, and S. M. Rowland, "Local drug delivery catheters: Functional comparison of porous and microporous designs," Coronary Artery Dis., 4, 469-175 (1993).
17. M. K. Hong, S. C. Wong, A. Farb, M. D. Mehlman, R. Virmani, J. J. Barry, and M. B. Leon, "Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery," Coronary Artery Dis., 4, 1023-1027 (1993).
18. A. M. Lincoff, J. G. Furst, S. G. Ellis, and E. J. Topol, "Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery," J. Am. Coll. Cardiol., 23, 18A (1994).
19. J. G. Murphy, R. S. Schwartz, W. D. Edwards, A. R. Camrud, R. E. Vlietstra, and D. R. Holmes, "Percutaneous polymeric stents in porcine coronary arteries: Initial experience with polyethylene terephthalate stents," Circulation, 86, 1596-1604 (1992).
20. D. W. M. Muller and S. G. Ellis, "Advances in coronary angioplasty: Endovascular stents," Coronary Artery Dis., 1, 438-448 (1990).
21. J. P. Carrozza, R. E. Kuntz, M. J. Levine, R. M. Pomerantz, R. F. Fishman, M. Mansour, C. M. Gibson, C. C. Senerchia, D. J. Diver, R. D. Safian, and D. S. Baim, "Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience," J. Am. Coll. Cardiol., 20, 328-337 (1992).
22. T. K. Nasser, R. L. Wilensky, K. Mehdi, and K. L. March, "Microparticle deposition in periarterial microvascular tube and intramural dissections after porous balloon delivery into atherosclerosis vessels: Quantitative and localization by confocal scanning laser microscopy," Am. Heart J., 131, 892-898 (1996).
23. I. Gradus-Pizlo, R. L. Wilensky, K. L. March, N. Fineberg, M. Michaels, G. E. Sandusky, and D. R. Hatnaway, "Local delivery of biodegradable microparticles containing a colchicine analogue: Effects of restenosis and implications for catheterbased drug delivery," J. Am. Coll. Cardiol., 26, 1549-1557 (1995).
24. P. Couvreur, P. Tulkens, M. Roland, A. Trouet, and P. Speiser, "Nanocapsules: A new type of lysosomotropic carrier," FEBS Lett., 84(2), 323-326 (1977).
25. A. Astier, B. Doat, M.-J. Ferrer, G. Benoit, J. Fleury, A. Rolland, and R. Leverge, "Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells," Cancer Res., 48, 1835-1841 (1988).
26. S. S. Davis and L. Illum, "Colloidal delivery systems-Opportunities and challenges," in Site-Specific Drug Delivery, E. Tomlinson, and S. S. Davis (eds.), John Wiley & Sons, Inc., New York, 1986, pp. 93-110.
27. B. Jeong, Y. H. Bae, D. S. Lee, and S. W. Kim. "Biodegradable block copolymers as injectable drug-delivery systems," Nature, 388, 860-862 (1997).
28. J. H. Campbell and G. R. Campbell, "Methods of growing vascular smooth muscle in culture," in Vascular Smooth Muscle in Culture, Vol. 1, J. H. Campbell and G. R. Campbell (eds.), CRC Press, Boca Raton, Florida, 1987, pp. 15-21.